查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1134986

睪固酮替代療法的全球市場規模調查&預測，各產品，各地區分析，2022-2029年

Global Testosterone Replacement Therapy Market Size study & Forecast, by Product (Injectables, Topicals, Others) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

睾酮替代療法睾酮有多種形式，例如乳液、注射劑、貼片、牙齦/臉頰粘合劑、凝膠或植入物。

老年人口的增加、不健康的生活方式和不斷增加的疾病負擔預計將增加睾酮缺乏症的患病率，這將在預測期內加速睾酮替代療法的市場擴張。睾酮缺乏症患病率上升和老年人口增加是預測期內推動市場增長的主要因素。

本調查的目的是定義近年來各個細分市場和國家的市場規模，並在未來幾年預測它們的價值。本報告設計內容涵蓋調查對象國家產業的定性和定量雙方面。

此外也提供市場未來性的成長促進因素和課題等重要方面相關之詳細資訊。再加上主要企業的競爭情形和提供產品之詳細分析，並涵括利害關係者投資所需的微觀市場潛在機會。詳細的市場區隔和子區隔如下列。

各產品

注射劑

外用劑

其他

各地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

義大利

其他歐洲

亞太地區

中國

印度

日本

澳洲

韓國

其他亞太地區

南美

巴西

墨西哥

全球其他地區

目錄

第1章 摘要整理

  • 市場概述
  • 世界·各分類市場估計·預測，2019-2029年
    • 睪固酮替代療法市場:各地區，2019年～2029年
    • 睪固酮替代療法市場:各產品，2019年～2029年
  • 主要趨勢
  • 調查手法
  • 調查前提條件

第2章 睪固酮替代療法的全球市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查目標範圍
    • 產業的演進
  • 調查對象年
  • 貨幣換算比率

第3章 睪固酮替代療法的全球市場動態

  • 睪固酮替代療法市場影響分析(2019-2029年)
    • 推動市場要素
    • 市場課題
    • 市場機會

第4章 全球睪固酮替代療法市場產業分析

  • 波特的5力模式
    • 供給企業談判力
    • 買方議價能力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 波特五力分析的未來性方法(2019-2029年)
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術性
  • 投資採用模式
  • 分析師的結論·建議
  • 頂級投資機會
  • 主要成功策略

第5章 風險評估:COVID-19衝擊

  • COVID-19對產業帶來的整體影響的評估
  • COVID-19以前和COVID-19以後的市場情景

第6章 睪固酮替代療法的全球市場:各產品

  • 市場概述
  • 睪固酮替代療法的全球市場:各產品，性能-潛在力分析
  • 睪固酮替代療法的全球市場，各產品估計·預測，2019-2029年
  • 睪固酮替代療法市場，子區隔分析
    • 注射劑
    • 外用藥
    • 其他

第7章 睪固酮替代療法的全球市場:各地區分析

  • 睪固酮替代療法市場，各地區市場概述
  • 北美
    • 美國
      • 各產品的估計·預測，2019年～2029年
    • 加拿大
  • 歐洲睪固酮替代療法市場概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他的歐洲地區
  • 亞太地區的睪固酮替代療法市場概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的睪固酮替代療法市場概述
    • 巴西
    • 墨西哥
  • 全球其他地區

第8章 競爭資訊

  • 頂級市場策略
  • 企業簡介
    • AbbVie Inc
      • 主要的資訊
      • 概要
      • 根據財務(依資料可得性)
      • 產品概要
      • 最近的開發情形
    • Endo Pharmaceuticals Inc
    • Pfizer, Inc
    • Eli Lilly and Company
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd
    • Ferring Pharmaceuticals
    • Acerus Pharmaceuticals Corporation
    • Mylan N.V
    • Perrigo Company Plc

第9章 調查流程

  • 調查流程
    • 資料探勘
    • 分析
    • 市場估計
    • 驗證
    • 出版
  • 調查屬性
  • 調查前提條件

Global Testosterone Replacement Therapy Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The distribution of testosterone during testosterone replacement treatment may take the form of lotions, injections, patches, gums/buccal adhesives, gels, or implants. A key male hormone called testosterone is in charge of enhancing spermatogenesis, male sexual traits, and reproduction. The prevalence of testosterone insufficiency is anticipated to rise as a result of the growing older population, unhealthy lifestyles, and disease load, which will accelerate the expansion of the market for testosterone replacement therapy over the forecasted period. Major driving factors driving the growth of the market over the forecasted period are growing prevalence of testosterone deficiency and growing number of geriatric populations.

The prevalence of testosterone deficiency in older men over 60 years of age increased by 21.67%, according to a December 2021 article in the Indian Journal of Endocrinology and Metabolism titled "Prevalence of Testosterone Deficiency in Elderly Male and its Association with Frailty and Mobility at a Tertiary Care Centre." Men's androgen levels gradually decline as they age. A need for treatment rather than testosterone is created by such testosterone overproduction, which propels market expansion. In the anticipated timeframe, market share will increase as a result of new product introductions. For instance, the AB generic version of AndroGel 1.62%, Testosterone Gel 1.62% Metered Dose Pump (20.25mg / 1.25g pump actuation), was developed by Xiromed LLC in August 2020. It is an alternate treatment for male diseases linked to persistent low testosterone or testosterone depletion. The negative consequences of testosterone replacement therapy and tight guidelines for product approval, however, will limit market expansion.

The key regions considered for the Global Testosterone Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America region is estimated to hold dominant position in the worldwide testosterone replacement therapy market over the forecast period, owing to rising number of product launches and approvals connected with androgen replacement therapy by regulatory agencies. For instance, Innovus Pharmaceuticals, Inc., a pharmaceutical firm in commercial development, got approval from Health Canada in February 2019 for its BH Testosterone Booster pills, which are designed to maintain testosterone levels and production in adult males. Additionally, the market for androgen replacement treatment is anticipated to rise significantly in Asia Pacific over the course of the projected period due to an increase in agreements by market participants. For instance, in August 2020, the pharmaceutical technology company Antares Pharma, Inc. and Lunatus Global Medical Supplies ('Lunatus') signed an exclusive distribution agreement for the distribution and marketing of XYOSTED, a testosterone enanthate injection, in Saudi Arabia and the United Arab Emirates (UAE).

Major market players included in this report are:

AbbVie Inc

Endo Pharmaceuticals Inc

Pfizer, Inc

Eli Lilly and Company

Bayer AG

Teva Pharmaceutical Industries Ltd

Ferring Pharmaceuticals

Acerus Pharmaceuticals Corporation

Mylan N.V

Perrigo Company Plc

Recent Developments in the Market:

  • KYZATREX was approved by the US Food and Drug Administration for Marius Pharmaceuticals in August 2022. (Testosterone undecanoate). KYZATREX is an oral testosterone replacement therapy ("TRT") that is recommended for adult males with hypogonadism or other diseases linked to a lack of endogenous testosterone.
  • The testosterone undecanoate (TLANDO), an oral treatment for testosterone replacement therapy, was approved by the US Food and Drug Administration (FDA) in March 2022.

Global Testosterone Replacement Therapy Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Injectables

Topicals

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Testosterone Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Testosterone Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Testosterone Replacement Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Testosterone Replacement Therapy Market Dynamics

  • 3.1. Testosterone Replacement Therapy Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of testosterone deficiency
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Strict rules and regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising initiatives by the key market players

Chapter 4. Global Testosterone Replacement Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Testosterone Replacement Therapy Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Testosterone Replacement Therapy Market by Product, Performance - Potential Analysis
  • 6.3. Global Testosterone Replacement Therapy Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
  • 6.4. Testosterone Replacement Therapy Market, Sub Segment Analysis
    • 6.4.1. Injectables
    • 6.4.2. Topicals
    • 6.4.3. Others

Chapter 7. Global Testosterone Replacement Therapy Market, Regional Analysis

  • 7.1. Testosterone Replacement Therapy Market, Regional Market Snapshot
  • 7.2. North America Testosterone Replacement Therapy Market
    • 7.2.1. U.S. Testosterone Replacement Therapy Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Testosterone Replacement Therapy Market
  • 7.3. Europe Testosterone Replacement Therapy Market Snapshot
    • 7.3.1. U.K. Testosterone Replacement Therapy Market
    • 7.3.2. Germany Testosterone Replacement Therapy Market
    • 7.3.3. France Testosterone Replacement Therapy Market
    • 7.3.4. Spain Testosterone Replacement Therapy Market
    • 7.3.5. Italy Testosterone Replacement Therapy Market
    • 7.3.6. Rest of Europe Testosterone Replacement Therapy Market
  • 7.4. Asia-Pacific Testosterone Replacement Therapy Market Snapshot
    • 7.4.1. China Testosterone Replacement Therapy Market
    • 7.4.2. India Testosterone Replacement Therapy Market
    • 7.4.3. Japan Testosterone Replacement Therapy Market
    • 7.4.4. Australia Testosterone Replacement Therapy Market
    • 7.4.5. South Korea Testosterone Replacement Therapy Market
    • 7.4.6. Rest of Asia Pacific Testosterone Replacement Therapy Market
  • 7.5. Latin America Testosterone Replacement Therapy Market Snapshot
    • 7.5.1. Brazil Testosterone Replacement Therapy Market
    • 7.5.2. Mexico Testosterone Replacement Therapy Market
  • 7.6. Rest of The World Testosterone Replacement Therapy Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. AbbVie Inc
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Endo Pharmaceuticals Inc
    • 8.2.3. Pfizer, Inc
    • 8.2.4. Eli Lilly and Company
    • 8.2.5. Bayer AG
    • 8.2.6. Teva Pharmaceutical Industries Ltd
    • 8.2.7. Ferring Pharmaceuticals
    • 8.2.8. Acerus Pharmaceuticals Corporation
    • 8.2.9. Mylan N.V
    • 8.2.10. Perrigo Company Plc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Testosterone Replacement Therapy Market, report scope
  • TABLE 2. Global Testosterone Replacement Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Testosterone Replacement Therapy Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Testosterone Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Testosterone Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Testosterone Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Testosterone Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Testosterone Replacement Therapy Market
  • TABLE 69. List of primary sources, used in the study of global Testosterone Replacement Therapy Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Testosterone Replacement Therapy Market, research methodology
  • FIG 2. Global Testosterone Replacement Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Testosterone Replacement Therapy Market, key trends 2021
  • FIG 5. Global Testosterone Replacement Therapy Market, growth prospects 2022-2029
  • FIG 6. Global Testosterone Replacement Therapy Market, porters 5 force model
  • FIG 7. Global Testosterone Replacement Therapy Market, pest analysis
  • FIG 8. Global Testosterone Replacement Therapy Market, value chain analysis
  • FIG 9. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Testosterone Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Testosterone Replacement Therapy Market, regional snapshot 2019 & 2029
  • FIG 15. North America Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Testosterone Replacement Therapy Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Testosterone Replacement Therapy Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable